Professional Profile

PHILOSOPHY

Associate Professor Grummet believes that the best patient care can be delivered now and into the future by upholding the three pillars of surgery – clinical care, education and research – and that all three are best performed by the practising urological surgeon.

A/Prof Jeremy Grummet is a urological surgeon with specific training and expertise in urological cancers. He is a pioneer of focal therapy for intermediate-risk localised prostate cancer, having started practising focal therapy in 2015 and is co-principal investigator on the LIBERATE focal brachytherapy clinical registry. He also performs MRI-targeted transperineal biopsy for maximal accuracy and minimal risk in prostate cancer diagnosis.

A/Prof Grummet also performs both robotic and open radical prostatectomy for the treatment of prostate cancer. He performs laparoscopic (keyhole) surgery for kidney cancer and radical cystectomy (bladder removal) for locally aggressive bladder cancer.

In addition to his expertise in uro-oncology, A/Prof Grummet also treats a wide range of general urological problems, performing minimally invasive surgery for kidney stones (using laser), benign prostate disease, and vasectomy.

A/Prof Grummet completed his formal training in urology obtaining his FRACS in 2007.  The following year he completed a Clinical Uro-Oncology Fellowship under the supervision of Dr Martin Gleave at the Prostate Centre in Vancouver, Canada. During his Fellowship year he helped establish the robotic prostatectomy program at Vancouver General Hospital and completed a Robotic Surgery Mini-Residency at the University of California Irvine under Dr Thomas Ahlering.

He has presented widely at multiple national and international conferences on the benefits of surgery for high risk localised prostate cancer, and is a strong advocate of active surveillance for low risk prostate cancer to minimise unnecessary treatment.  He was a site investigator at Alfred Health on the PRIAS study, the largest worldwide study assessing outcomes for patients on active surveillance. 

A/Prof Grummet has extensive experience in performing transperineal biopsy for the diagnosis of prostate cancer and has run workshops teaching the technique to other urologists.  This technique provides excellent tissue sampling as well as a near-zero risk of serious infection. He conducts multiple clinical research projects on prostate cancer diagnostics and established the Victorian Transperineal Biopsy Collaboration (VTBC) research group in 2013. He also established the MRI Prostate Multidisciplinary Meeting at Epworth Healthcare in 2014. In 2017, A/Prof Grummet was an invited speaker in a plenary session debate on transperineal biopsy at the American Urological Association's Annual Meeting in Boston, USA.

In 2018, A/Prof Grummet became the first non-European EAU (European Association of Urology) Prostate Cancer Guidelines Panel member. The EAU Guidelines are renowned as the premier source of evidence-based guidelines for urological practice in the world, and are endorsed by USANZ. A/Prof Grummet completed his service on the Panel in 2023.

A/Prof Grummet has been involved in additional clinical research as an investigator in multi-centre trials including the assessment of:

- the therapeutic effect of Enzalutamide in newly diagnosed metastatic prostate cancer (ENZAMET)
- a decision aid for active surveillance of patients with low risk prostate cancer (ASTROID)
- lower urinary tract symptoms (LUTS) in patients with advanced prostate cancer
- sexual dysfunction in men on medical therapy for LUTS due to benign prostate enlargement.

In 2014, as a principal investigator on an ANZUP research team with oncologist Professor Ian Davis, A/Prof Grummet was awarded nearly $600,000 in competitive grant funding from Cancer Australia and the Prostate Cancer Foundation of Australia (PCFA) to conduct a multi-centre randomised control trial comparing different methods of pain relief for prostate biopsy, Painfree TRUS B.

A/Prof Grummet was a council member of Foundation 49 Men's Health group, and contributes regularly to educational material provided by Healthy Male. Through the China-ANZ Project he has established an educational relationship with the Urology Department at Sir Run Run Shaw Hospital in Hangzhou, China. He has made several visits providing updates in the latest standard of urological care and learnt Mandarin to Year 12.